Nosocomial infections: new therapeutic alternatives

Expert Rev Anti Infect Ther. 2010 Nov;8(11):1217-9. doi: 10.1586/eri.10.133.

Abstract

This symposium on nosocomial infections, antimicrobial resistance and the benefits of doripenem in this setting was held in Madrid, Spain, on 7 October 2009, and was supported by Janssen-Cilag. The topic was presented under an interdisciplinary approach by different international experts in the field.

Publication types

  • Congress

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Carbapenems / adverse effects
  • Carbapenems / pharmacokinetics
  • Carbapenems / pharmacology*
  • Carbapenems / therapeutic use*
  • Cross Infection / drug therapy*
  • Doripenem
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Doripenem